FDA Inspection 1113080 — AbbVie Bioresearch Center
The FDA completed an inspection of AbbVie Bioresearch Center on November 18, 2019 in Worcester, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 18, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Worcester, MA (United States)